VAPOGENIX, INC.
HOUSTON, TX · CIK 0001628848 · Medtech
Topically administered formulated volatile anesthetics (sevoflurane) for local pain and inflammation relief
vapogenix.com →- Grants
- $1.1M
- 2 awards
- Sector median: 1
- Raised
- $12M
- 3 Form D · Jan 2018
- 105 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 6 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,100,000 | |
| Private capital raised | Form D · SEC | $7,978,130 | |
| Private capital raised | Form D · SEC | $1,633,764 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Use of Volatile Anesthetics as Topical Treatment for Painful Inflammatory Conditions: Interactions with Integrins and In Vivo Anti-inflammatory Effects. | $223,735 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Formulated Sevoflurane as a Novel Topical Treatment for Painful Inflammatory Conditions | $907,683 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1019 | Cardiac Motion, LLC | — | — |
| 1020 | Happy Home Company, Inc. | — | $2.5M |
| 1021 | HARD TO TREAT DISEASES INC | — | $58K |
| 1022 | VAPOGENIX, INC. | — | $12M |
| 1023 | Boston Incubation Center LLC | — | — |
| 1024 | Fio Corp | — | $11M |
| 1025 | Windgap Medical, Inc. | — | $41M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Danguole AltmanDirector · Executive Officer
- Motter ClariceExecutive Officer
- George DavittDirector
- Bruce GivenDirector
- Clay HeightenDirector
- Christopher JorgensenDirector
- Christopher JorgesonDirector
- Marc LoevDirector
- Danguole SpakeviciusDirector · Executive Officer
Patents
- Analgesic Compositionsgranted
- Novel Formulations And Methods For Treating Dermatological Disorders Or Diseasesapplication
- Novel Formulations And Methods For Treating Dermatological Disorders Or Diseasesgranted
- Analgesic Compositionsgranted
- Analgesic Compositionsgranted
- Novel Analgesic Compositionsgranted
- Novel Analgesic Compositionsgranted
- Novel Analgesic Compositionsapplication
- Novel Formulations And Methods For Treating Dermatological Disorders Or Diseasesapplication
- Novel Formulations Of Volatile Anesthetics And Methods Of Use For Reducing Inflammationapplication
- Volatile Anesthetic Compositions And Methods Of Useapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.